Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
Reframing the Construction Manager as a Community Manager
Health First Celebrates 'Topping Off' Ceremony for New Cape Canaveral Hospital Campus
The University of Hawai'i Cancer Center Caught Up in Cyberattack
Mature Dry Surface Biofilm Presents a Problem for Candida Auris
Sutter Health's Arden Care Center Officially Opens